
Francesca Barone
@baroneexpmed
Clinician scientist in love with experimental medicine.
ID: 966388043950194688
21-02-2018 19:03:59
561 Tweet
371 Followers
325 Following

President and CEO,Dr. Paul Peter Tak, MD, PhD, FMedSci, CSO Francesca Barone, MD, PhD, and VP of Finance & Corporate Controller, Charles Schoch are kicking off 2024 at the 42nd Annual J.P. Morgan Healthcare conference. Be sure to say hello! #JPMorgan2024 #JPM24



Safe and feasible intratumoral CAN-2409 delivery on outpatient basis can reinvigorate immune response in ICI refractory #NSCLC and extend survival. Charu Aggarwal, MD, MPH, FASCO Perlmutter Cancer Center at NYU Langone Health NYU Langone Health #ASCO24





Adam Feuerstein ✡️ Candel Therapeutics Manufacturing. While we continued to advance analytical development and comparability studies successfully, and locked the process, we did not want to spend tens of millions of $$ on large scale manufacturing before data read out - a concept that we call dynamic portfolio


Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome nature.com/articles/s4146… Nature Communications Francesca Barone



Combination of surgical upfront immunotherapy with aglatimagene besadenovec (CAN-2409), followed by chemoradiation and then adjuvant nivolumab for newly diagnosed glioblastoma (Wen et al. March 2025, SNO). E. Antonio Chiocca, MD, PhD, FAANS & Dr. Paul Peter Tak





Great day for Candel Therapeutics !!!! linkedin.com/posts/francesc…